Training the Medicine Makers the UK Can’t Afford to Lose
Why immersive training could be critical to closing the UK’s medicines manufacturing skills gap
Clinical Scorecard: Training the Medicine Makers the UK Can’t Afford to Lose
At a Glance
| Category | Detail |
|---|
| Condition | Skills gap in life sciences and pharmaceutical manufacturing, with an urgent need for skilled professionals. |
| Key Mechanisms | |
| Target Population | |
| Care Setting | |
Key Highlights
- 41% decline in industry clinical trials initiated in the UK from 2017 to 2021 (source needed)
- Forecast requirement of 145,000 new jobs in the Bio/Pharma industry in the next decade (source needed)
Guideline-Based Recommendations
Diagnosis
Management
- Implement VR-based training programs to enhance skills in medicine manufacturing, citing successful case studies.
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Not applicable as this focuses on training rather than direct patient care
VR training reduces costs and improves access to training resources
Clinical Best Practices
- Incorporate feedback mechanisms to refine training programs, and address the lack of haptic feedback in VR training.
References
